Comparison of Hylastan to Methylprednisolone Acetate in Patients With Symptomatic Osteoarthritis of the Knee
NCT ID: NCT00139295
Last Updated: 2014-02-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
INTERVENTIONAL
2004-10-31
2007-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Durolane Versus Methylprednisolone in Knee Osteoarthritis
NCT01209364
Phase III Study on the Safety and Efficacy of a Single Intra-articular Administration of JTA-004 in Symptomatic Knee Osteoarthritis
NCT04333160
Intra-articular Corticosteroid Injection Compared With Single-Shot Hyaluronic Acid for Treatment of Osteoarthritis Knee
NCT01874574
A Study Comparing Viscosupplementation and Corticosteroid Injections for Knee Osteoarthritis
NCT01132677
Treatment for Patients With Osteoarthritis (OA) of the Knee
NCT00110916
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hylastan
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have tried but not been sufficiently helped by conservative treatment, such as weight reduction and pain medications
Exclusion Criteria
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Genzyme, a Sanofi Company
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Genzyme Corporation
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Medical Monitor
Role: STUDY_DIRECTOR
Genzyme, a Sanofi Company
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Capstone Clinical Trials, Inc
Birmingham, Alabama, United States
Hope Research Institute, LLC
Phoenix, Arizona, United States
Tucson Orthopedic Institute, PC
Tucson, Arizona, United States
Orthopaedic Specialties of Tampa Bay
Clearwater, Florida, United States
Northwestern Center for Clinical Research
Chicago, Illinois, United States
Midwest Orthopedics at Rush University Medical Center
Chicago, Illinois, United States
Rockford Health Physicians
Rockford, Illinois, United States
Bluegrass Orthopaedics/Bluegrass Musculoskeletal Research
Lexington, Kentucky, United States
Orthopedic Specialists of Louisiana
Shreveport, Louisiana, United States
Arthritis & Osteoporosis Center of Maryland
Frederick, Maryland, United States
Clinical Pharmacology Study Group
Worcester, Massachusetts, United States
Orthopedic Center for Joint Replacement and Sports
Grants Pass, Oregon, United States
Coastal Orthopedic Associates
Conway, South Carolina, United States
Unlimited Research
San Antonio, Texas, United States
Arthritis Northwest
Seattle, Washington, United States
Sir William Osler Health Institute
Hamilton, Ontario, Canada
Clinique du Sport
Mérignac, , France
Centre Hospitalier Lyon-Sud, Service de Rhumatologie
Pierre-Bénite, , France
CHU Hôpital Trousseau Service de Rhumatologie
Tours, , France
St-Elisabeth Klinik, Orthopädisch Gemeinschaftspraxis
Heidelberg, , Germany
Orthopaedische Gemeinschaftspraxis
Weyhe-Kirchweyhe, , Germany
Southampton General Hospital, MRC Environmental Epidemiology Unit
Southampton, Hampshire, United Kingdom
Maidstone General Hospital & Tunbridge Wells NHS Trust
Maidstone, Kent, United Kingdom
Whipps Cross University Hospital NHS Trust, Arthritis Assessment, Physiotherapy Department
Leytonstone, London, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AVS00103
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.